Recipharm, a firm that specializes in contract development and manufacture of pharmaceuticals, and the Government of Morocco to form SENSYO Pharmatech, a firm that engaged in the development and operation of a new fill & finish vaccines and biologics facility, in a $276m deal. "We are proud to be involved as the CDMO of choice in this fantastic step forward for Morocco and Africa. Breaking ground on a facility of this magnitude is a significant milestone and reflects the depth of our joint commitment to meeting Morocco's long term healthcare needs," Marc Funk, Recipharm CEO.